- Home
- PNW vs AXSM Comparison
PNW vs AXSM Comparison
Compare PNW & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNW | AXSM |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.0B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PNW | AXSM |
|---|---|---|
| Price | $101.51 | $214.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 17 |
| Target Price | $100.21 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 1.1M | 706.7K |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ 1.70 | N/A |
| Revenue | ★ $5,339,939,000.00 | N/A |
| Revenue This Year | $5.15 | $57.24 |
| Revenue Next Year | $6.89 | $55.88 |
| P/E Ratio | $59.25 | ★ N/A |
| Revenue Growth | ★ 4.20 | N/A |
| 52 Week Low | $85.32 | $109.40 |
| 52 Week High | $111.16 | $260.19 |
Technical Indicators
Market Signals| Indicator | PNW | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 43.78 | 41.14 |
| Support Level | $100.88 | $206.94 |
| Resistance Level | $103.98 | $236.26 |
| Average True Range (ATR) | 2.06 | 8.99 |
| MACD | -0.13 | -0.49 |
| Stochastic Oscillator | 30.67 | 21.76 |
Price Performance
Historical ComparisonAbout PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.